Vicarious Surgical Inc. income statement RBOT

It recorded a net loss of $50.2 million.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Research and development
34
-16.3%
40
-15.6%
48
+8.4%
44
+99.0%
22
Selling, general and administrative
17
-34.2%
26
-20.2%
33
-8.5%
36
+123.8%
16
Operating income
-50
+24.8%
-67
+17.5%
-81
-0.7%
-80
-109.5%
-38
Other income (expense)
-0
—
—
—
—
Pretax income
-50
+20.6%
-63
+11.0%
-71
-1478.1%
5
+114.6%
-35
Net income
-50
+20.6%
-63
+11.0%
-71
-1478.1%
5
+114.6%
-35
Basic EPS
—
—
-0.49
-1325.0%
0.04
+111.1%
-0.36
Diluted EPS
—
—
-0.49
-1325.0%
0.04
+111.1%
-0.36
Weighted average shares, basic
6
+4.2%
6
+20.9%
5
-96.0%
122
—
Weighted average shares, diluted
6
+4.2%
6
+20.9%
5
-96.2%
128
+31.9%
97
Other measures
Depreciation and amortization
1
-32.4%
2
+13.6%
2
+66.9%
1
+251.6%
0
EBITDA
-49
+24.6%
-64
+18.2%
-79
+0.2%
-79
-108.3%
-38
Interest coverage
—
-2,662.20x
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
RBOT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
, Emerging growth company
SEC CIK
1812173
Former names
D8 Holdings Corp. (until Sep 20, 2021)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.